GLOBUS MEDICAL INC - Class A Stock (GMED) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Class A Stock
Symbol
GMED on NYSE
Shares outstanding
115,244,363
Price per share
$92.98
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
111,068,229
Total reported value
$9,701,797,193
% of total 13F portfolios
0.02%
Share change
+61,640
Value change
+$149,278,659
Number of holders
553
Price from insider filings
$92.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GLOBUS MEDICAL INC - Class A Stock (GMED) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.1% +16% $778,991,964 -$11,095,352 10,487,237 -1.4% BlackRock, Inc. 31 Mar 2025
JANUS HENDERSON GROUP PLC 6.1% +5% $522,135,958 +$30,787,723 7,029,294 +6.3% JANUS HENDERSON GROUP PLC 31 Mar 2025

As of 31 Dec 2025, 553 institutional investors reported holding 111,068,229 shares of GLOBUS MEDICAL INC - Class A Stock (GMED). This represents 96% of the company’s total 115,244,363 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of GLOBUS MEDICAL INC - Class A Stock (GMED) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.2% 10,549,455 -0.53% 0.01% $921,072,916
BlackRock, Inc. 8.9% 10,284,093 -2.4% 0.02% $897,904,166
JANUS HENDERSON GROUP PLC 6.3% 7,294,878 -3.4% 0.29% $636,916,203
Invesco Ltd. 3.4% 3,886,405 +1235% 0.05% $339,322,022
STATE STREET CORP 3% 3,463,845 +0.06% 0.01% $302,428,307
BANK OF MONTREAL /CAN/ 2.9% 3,373,260 +15317% 0.12% $294,519,330
JPMORGAN CHASE & CO 2.7% 3,098,773 -16% 0.02% $270,553,943
Sculptor Capital LP 2.6% 3,000,000 -14% 3.2% $261,930,000
Madison Avenue Partners, LP 2.3% 2,624,751 +3% 9.8% $229,167,010
CITADEL ADVISORS LLC 2.2% 2,539,396 +2165% 0.15% $221,714,665
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.2% 2,519,782 -11% 0.61% $220,002,166
GEODE CAPITAL MANAGEMENT, LLC 1.8% 2,056,774 -0.3% 0.01% $179,614,258
GENEVA CAPITAL MANAGEMENT LLC 1.7% 1,901,974 -8.7% 3.1% $166,061,363
ALLIANCEBERNSTEIN L.P. 1.6% 1,844,958 -10% 0.05% $161,083,283
DIMENSIONAL FUND ADVISORS LP 1.5% 1,735,921 -14% 0.03% $151,567,419
GW&K Investment Management, LLC 1.3% 1,516,345 -15% 1.1% $132,392,000
Boston Trust Walden Corp 1.2% 1,367,987 +15% 0.9% $119,438,945
Vestal Point Capital, LP 1.1% 1,275,000 +2% 4.1% $111,320,250
Parsifal Capital Management, LP 1.1% 1,222,717 +11% 11% $106,755,421
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 1,190,617 -1.1% 0.02% $103,952,770
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.96% 1,105,606 +129818% 0.12% $103,475,000
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.96% 1,101,866 -14% 0.08% $96,203,920
FULLER & THALER ASSET MANAGEMENT, INC. 0.9% 1,035,518 0.31% $90,411,073
NORGES BANK 0.89% 1,029,913 0.01% $89,921,704
MARSHALL WACE, LLP 0.85% 975,896 -43% 0.08% $85,205,481

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 111,068,229 $9,701,797,193 +$149,278,659 $87.31 553
2025 Q3 115,933,964 $6,654,707,679 +$72,456,317 $57.27 488
2025 Q2 114,075,801 $6,730,550,265 +$195,769,879 $59.02 477
2025 Q1 109,345,858 $7,997,914,722 -$8,993,495 $73.20 507
2024 Q4 108,904,887 $9,007,980,911 +$44,310,752 $82.71 495
2024 Q3 108,072,594 $7,734,964,942 -$332,078,125 $71.54 444
2024 Q2 112,764,178 $7,722,959,830 -$3,143,182 $68.49 443
2024 Q1 113,402,229 $6,082,679,016 +$359,376,321 $53.64 435
2023 Q4 106,692,854 $5,685,431,048 -$155,605,070 $53.29 405
2023 Q3 109,414,808 $5,433,176,387 +$1,362,204,600 $49.65 426
2023 Q2 81,374,906 $4,843,899,307 +$408,515,363 $59.54 378
2023 Q1 74,600,238 $4,224,726,594 -$151,471,403 $56.64 381
2022 Q4 75,948,098 $5,639,196,814 +$86,702,611 $74.27 383
2022 Q3 74,451,382 $4,436,437,568 +$100,448,577 $59.57 356
2022 Q2 72,222,203 $4,054,750,490 +$112,004,727 $56.14 349
2022 Q1 69,530,797 $5,130,106,470 +$81,009,114 $73.78 366
2021 Q4 68,345,177 $4,935,105,853 +$7,508,095 $72.20 367
2021 Q3 67,700,811 $5,190,187,299 -$70,035,321 $76.62 380
2021 Q2 68,045,932 $5,276,020,366 +$27,082,820 $77.53 351
2021 Q1 67,739,467 $4,178,223,997 +$52,788,626 $61.67 338
2020 Q4 66,616,139 $4,344,582,646 +$137,526,882 $65.22 343
2020 Q3 64,418,606 $3,189,910,125 -$115,537,152 $49.52 336
2020 Q2 66,705,847 $3,180,329,751 -$236,172,306 $47.71 312
2020 Q1 71,806,963 $3,053,523,816 +$121,157,476 $42.53 266
2019 Q4 67,279,881 $3,960,808,169 -$28,832,985 $58.88 304
2019 Q3 68,078,022 $3,478,746,497 +$23,175,292 $51.12 266
2019 Q2 67,934,676 $2,873,736,931 +$68,262,206 $42.30 255
2019 Q1 66,704,822 $3,293,778,190 -$65,694,730 $49.41 264
2018 Q4 68,249,962 $2,953,271,922 +$98,486,796 $43.28 301
2018 Q3 65,487,760 $3,715,590,483 +$107,199,480 $56.76 310
2018 Q2 63,650,675 $3,211,939,865 +$91,311,533 $50.46 285
2018 Q1 61,964,717 $3,079,267,072 -$55,501,163 $49.82 276
2017 Q4 63,316,479 $2,600,052,259 -$177,983,391 $41.10 254
2017 Q3 68,779,684 $2,044,301,959 +$133,468,390 $29.72 247
2017 Q2 63,912,936 $2,113,531,840 -$6,742,413 $33.15 240
2017 Q1 66,448,625 $1,968,206,890 +$212,215,068 $29.62 240
2016 Q4 66,416,082 $1,647,898,444 +$49,757,687 $24.81 204
2016 Q3 65,110,721 $1,468,682,032 -$90,108,711 $22.57 191
2016 Q2 68,944,209 $1,642,903,804 +$5,899,417 $23.83 203
2016 Q1 69,470,642 $1,648,818,412 +$41,022,318 $23.75 200
2015 Q4 66,193,785 $1,841,465,465 +$9,162,505 $27.82 185
2015 Q3 66,646,506 $1,376,939,977 +$85,476,007 $20.66 178
2015 Q2 62,535,892 $1,605,270,230 -$1,848,789 $25.67 177
2015 Q1 62,724,615 $1,582,790,729 +$33,704,934 $25.24 178
2014 Q4 61,313,895 $1,457,510,086 +$92,436,342 $23.77 181
2014 Q3 57,176,622 $1,124,529,205 +$35,352,082 $19.67 163
2014 Q2 54,426,902 $1,301,914,540 +$4,051,848 $23.92 174
2014 Q1 53,176,394 $1,411,676,236 +$60,435,010 $26.59 157